Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting

• Status: Completed
• Trial end date: 2015-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to give children with gastroenteritis with persistent vomiting flavored intravenous ondansetron orally. The investigators test the palatability of the drug and check the serum level of ondansetron at 4 hours .

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hamad Medical Corporation
• Treatments: Ondansetron

Criteria

Inclusion Criteria:

• children 3-8 years of age.

• acute simple gastroenteritis with mild to moderate dehydration.

• more than 2 episodes of vomiting in 24 hours period.

Exclusion Criteria:

• known hypersensitivity to ondansetron.

• seizure disorder.

• chronic liver or kidney diseases.

• on any chronic medication.